Physician profile
Charles Cooper
NPI 1235557695
$2,323.35
in general payments reported to CMS, 2019-2025
10 companies · $90.70 in 2025
The $90.70 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $24.68 · 2021: $1,622 · 2022: $169 · 2023: $14.92 · 2024: $296 · 2025: $90.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,508.66 | 2021 | |
| Medtronic, INC. | $296.30 | 2024 | Interstim, Eea |
| Ethicon US, LLC | $184.29 | 2022-2023 | Dermabond Prineo, Enseal |
| Tela Bio, INC. | $112.93 | 2021 | |
| Shire North American Group INC | $105.79 | 2019 | |
| Kerecis Limited | $32.57 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Baxter Healthcare | $24.68 | 2020 | |
| Mimedx Group, INC. | $23.87 | 2025 | |
| Acera Surgical, INC. | $18.33 | 2025 | Restrata Wound Matrix |
| Braintree Laboratories, INC. | $15.93 | 2025 | Suflave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.